ONKOLOGISK FORUM
Trondheim November 19.-20.
MAIN PROGRAM 2026
THURSDAY NOVEMBER 19th
Turid Lund, St Olavs Hospital and Petter Brandal, Oncology Forum Board
09:00 - 09:15 Opening
09:15 - 09:55 Sweat, Science, Spandex and Cancer: The Story of the CHALLENGE Trial
Christopher Booth, Queens University and Kingston Health Sciences Centre, Canada
09:55 - 10:15 High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM)
Gitte Holmen Olfusson, University of Copenhagen, Denmark
10:15 - 10:30 Discussion - How do we do it?
Lene Thorsen, Oslo University Hospital
10:30 - 11:00 Coffee break
11:00 - 11:20 Common Sense Oncology: Delivering Outcomes that matter
Christopher Booth, Queens University and Kingston Health Sciences Centre, Canada
11:20 - 11:30 Why Choosing Wisely?
The Norwegian Medical Association
11:30 - 11:40 Common Sense Oncology in Norway
Meetali Kakad, Akershus University Hospital
11:40 - 11:50 The experience with Choosing Wisely
Oddbjørn Straume, Haukeland University Hospital
11:50 - 12:00 Discussion
12:00 - 13:30 Lunch/exhibition
13:30 - 17:30 Parallell sessions for the National Diagnose Cancer Groups
Norsk Bryst Cancer Gruppe
Norsk Gastrointestinal Cancer Gruppe
Norsk Lunge Cancer Gruppe
Norsk Lymfom Gruppe
Norsk Forening for Gynekologisk Onkologi
Norsk Melanom Gruppe
Norsk Nevroonkologisk Interessegruppe
Norsk Forening for Palliativ Medisin
Norsk Gruppe for Hode Hals Cancer
Norsk Urologisk Cancer Gruppe
Nasjonal Kompetansetjeneste for Seneffekter etter Kreftbehandling
Norsk Presisjonsmedisinsk Cancer Gruppe
FRIDAY NOVEMBER 20th
09:00 - 09:30 Geriatric Assessment in Cancer Care and Clinical Trials
Hans Wilders UZ Leuven, Belgium
09:30 - 09:45 Geriatric Oncology in Norway
Nienke de Glas, Helse Førde
09:45 - 10:00 King Olav V's Cancer Research Award 2026
Johanna Olweus, Oslo University Hospital
10:00 - 10:20 Coffee break
10:20 - 10:35 Oncology Forum Career Scholarship 2026
Kjetil Taskén, Oslo University Hospital
10:35 - 11:05 Managing Immune-Related Adverse Events in Clinical Practice: From early detection to steroid-refractory disease and outpatient follow-upe
Anna Olsson-Brown, University Hospital Sussex, UK
11:05 - 11:35 Radiotherapy in breast cancer 2030 – is there a role for proton therapy and what will we learn from the PARABLE study?
Anna Kirby, Royal Marsden, London, UK
11:35 - 13:15 Lunch
13:15 - 12:45 How will AI change our radiotherapy practice?
Andrew Hope, Princess Margaret Cancer Center, Canada
12:45 - 13:15 Where are we with clinical AI in oncology - what does the near future look like?
tbc
13:15 - 13:35 Title to be decided
Magnus Løberg, Oslo University Hospital
13:35 - 13:45 Title to be decided
Kristine Ramheim Randel, Cancer Registry of Norway
13:45 - 13:55 Title to be decided
Marius Kuras Skram, The Norwegian Directorate of Health
14:00 Conclusion
